Merck KGaA Raises Guidance on Strong Second Quarter Results

Merck KGaA delivered strong second-quarter results for fiscal 2026, with group net sales increasing by 3.4% year-over-year to EUR 5.434 billion and organic growth reaching 4.1%. EBITDA pre rose 9.4% to EUR 1.6 billion, while EPS pre advanced 6.9% to EUR 2.16.

Growth was broad-based across the portfolio, with Life Science organic sales increasing by 8%, driven by strong demand in Process Solutions and Advanced Solutions. Electronics delivered organic growth of 11.7%, powered by Semiconductor Solutions' 17% surge, driven by AI-related demand in advanced logic and memory.

The company raised its full-year guidance for the second time this year, citing stronger momentum in Life Science and Electronics and easing FX headwinds. Group net sales growth is now expected at 1%-3%, with EBITDA pre of EUR 5.9-6.3 billion and EPS pre of EUR 7.90-8.60.